LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation
Gerontology · 2024
DOI: 10.1159/000541719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gerontology, 2024. Verfasst von Yuqi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Suppressor of Cytokine Signaling 3 Protein, DNA Methylation, Disease Progression. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Introduction
Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been shown to be involved in Parkinson’s disease (PD) progression, but its mechanism needs to be further explored.
Methods
Mice were injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce PD mice models, and BV2 cells were treated with lipopolysaccharides (LPS) to mimic PD cell models. MALAT1 expression and suppressor of cytokine signaling 3 (SOCS3) protein level were examined using quantitative real-time PCR and Western blot, respectively. Cell functions were tested by cell counting kit 8 assay and flow cytometry. The interaction between MALAT1 and SOCS3 was confirmed using RNA pull-down and RIP assays.
Results
MALAT1 was upregulated in MPTP-induced PD mice and LPS-induced BV2 cells. Silencing of MALAT1 increased viability, while inhibiting apoptosis and inflammation in LPS-induced BV2 cells. Besides, MALAT1 enhanced the SOCS3 promoter methylation to decrease its expression by recruiting DNMT1, DNMT3A, and DNMT3B. Furthermore, SOCS3 knockdown eliminated sh-MALAT1-mediated the inhibition effect on LPS-induced BV2 cell injury. In vivo, MALAT1 silencing ameliorated neurological impairment and neuroinflammation in MPTP-induced PD mice.
Conclusion
Our data revealed that MALAT1 worsened PD processes via inhibiting SOCS3 expression by increasing its promoter methylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- General Medicine Department, Guizhou Provincial People's Hospital, Guiyang, China.
- Zunyi Medical University, Zunyi, China.
Zitieren
APA
Liu, Y., Feng, D., Liu, F., Liu, Y., Zuo, F., Wang, Y., Chen, L., Guo, X., & Tian, J. (2024). LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation. Gerontology. https://doi.org/10.1159/000541719
Vancouver
Liu Y, Feng D, Liu F, Liu Y, Zuo F, Wang Y, et al. LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation. Gerontology. 2024. doi:10.1159/000541719
BibTeX
@article{Liu2024,
author = {Liu, Yuqi and Feng, Dan and Liu, Fenfen and Liu, Yun and Zuo, Fangya and Wang, Yujie and Chen, Lanlan and Guo, Xiuhong and Tian, Jinyong},
title = {LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation},
journal = {Gerontology},
year = {2024},
doi = {10.1159/000541719}
}
EUVIMED